Cargando…

Metabolic risk factors are associated with non‐hepatitis B non‐hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B

Metabolic risk factors, such as obesity, fatty liver, high lipidemia, and diabetes mellitus are associated with increased risk for nonviral hepatocellular carcinoma (HCC); however, few nonviral HCC studies have stratified patients according to underlying etiologies. From 2005 to 2011, 3,843 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shiu‐Feng, Chang, Il‐Chi, Hong, Chih‐Chen, Yen, Tseng‐Chang, Chen, Chao‐Long, Wu, Cheng‐Chung, Tsai, Cheng‐Chung, Ho, Ming‐Chih, Lee, Wei‐Chen, Yu, Hsien‐Chung, Shen, Ying‐Ying, Eng, Hock‐Liew, Wang, John, Tseng, Hui‐Hwa, Jeng, Yung‐Ming, Yeh, Chau‐Ting, Chen, Chi‐Ling, Chen, Pei‐Jer, Liaw, Yun‐Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983169/ https://www.ncbi.nlm.nih.gov/pubmed/29881825 http://dx.doi.org/10.1002/hep4.1182

Ejemplares similares

The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network
por: Chang, Il-Chi, et al.
Publicado: (2016)

Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection
por: Yang, Wan-Ting, et al.
Publicado: (2016)

Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection
por: Huang, Cih-En, et al.
Publicado: (2022)

Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
por: Wu, Jer-Wei, et al.
Publicado: (2021)

Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitis
por: Wu, Hsin-Yun, et al.
Publicado: (2023)

Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment
por: Kuo, Meng Hsuan, et al.
Publicado: (2021)

Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment
por: Liu, Chun Jen, et al.
Publicado: (2021)

Elimination of Hepatitis B: Is It a Mission Possible?
por: Tseng, Tai-Chung, et al.
Publicado: (2017)

Impact of Genetic Heterogeneity in Polymerase of Hepatitis B Virus on Dynamics of Viral Load and Hepatitis B Progression
por: Huang, Chi-Jung, et al.
Publicado: (2013)

Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
por: Jang, Tyng-Yuan, et al.
Publicado: (2023)

Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease
por: Lin, Meng-Ju, et al.
Publicado: (2023)

Elimination of Hepatitis B in Highly Endemic Settings: Lessons Learned in Taiwan and Challenges Ahead
por: Liu, Chun-Jen, et al.
Publicado: (2020)

Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses
por: Chang, Ming-Ling, et al.
Publicado: (2022)

Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease
por: Lin, Meng-Ju, et al.
Publicado: (2023)

H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection
por: Shen, Yu-Chuan, et al.
Publicado: (2022)

Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC
por: Yeh, Shiou-Hwei, et al.
Publicado: (2023)

Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy
por: Shih, Chih-An, et al.
Publicado: (2021)

Hepatitis C virus and hepatitis B virus in patients with schizophrenia
por: Chang, Chun-Hung, et al.
Publicado: (2021)

CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection
por: Yeh, Chau-Ting, et al.
Publicado: (2009)

Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic
por: Tai, Chi-Ming, et al.
Publicado: (2023)

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

An Occult Hepatitis B-Derived Hepatoma Cell Line Carrying Persistent Nuclear Viral DNA and Permissive for Exogenous Hepatitis B Virus Infection
por: Lin, Chih-Lang, et al.
Publicado: (2013)

IL28B Polymorphism Correlates with Active Hepatitis in Patients with HBeAg-Negative Chronic Hepatitis B
por: Lee, I-Cheng, et al.
Publicado: (2013)

The Impact of Human Platelet Antigen Allele on Antiplatelet Antibodies and Cryoglobulins in Patients with Primary Immune Thrombocytopenia and Hepatitis C Virus-Associated Immune Thrombocytopenia
por: Huang, Cih-En, et al.
Publicado: (2023)

Phenotypic and Genotypic Shifts in Hepatitis B Virus in Treatment-Naive Patients, Taiwan, 2008–2012
por: Yeh, Chau-Ting, et al.
Publicado: (2017)

Increased risk of hepatic complications in kidney transplantation with chronic virus hepatitis infection: A nationwide population-based cohort study
por: Yu, Tung-Min, et al.
Publicado: (2016)

Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
por: Lin, Hung-Yao, et al.
Publicado: (2022)

Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
por: Liu, Chen-Hua, et al.
Publicado: (2021)

Longitudinal changes in physical and mental health of older adults with chronic hepatitis B infection: Trajectories and predictors
por: Chen, Chang-Hua, et al.
Publicado: (2021)

Another oral antiviral treatment, but still far away from hepatitis B virus cure
por: Tseng, Tai-Chung
Publicado: (2021)

Non-Invasive Evaluation of Hepatic Fibrosis: The Diagnostic Performance of Magnetic Resonance Elastography in Patients with Viral Hepatitis B or C
por: Wu, Wen-Pei, et al.
Publicado: (2015)

Moderate Risk of Hepatitis B Virus Reactivation in HBsAg(−)/HBcAb(+) Carriers Receiving Rituximab for Rheumatoid Arthritis
por: Kuo, Meng Hsuan, et al.
Publicado: (2020)

Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
por: Liu, Chen-Hua, et al.
Publicado: (2018)

Circulating Programmed Death-1 as a Marker for Sustained High Hepatitis B Viral Load and Risk of Hepatocellular Carcinoma
por: Cheng, Hsiang-Yun, et al.
Publicado: (2014)

Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas
por: Lan, Ting-Yuan, et al.
Publicado: (2023)

Hepatic decompensation during paritaprevir/ritonavir/ombitasvir/dasabuvir treatment for genotype 1b chronic hepatitis C patients with advanced fibrosis and compensated cirrhosis
por: Hsieh, Yi-Chung, et al.
Publicado: (2018)

Overt Acute Hepatitis B Deteriorates in Females: Destructive Immunity With an Exaggerated Interleukin-17 Pathway
por: Chang, Ming-Ling, et al.
Publicado: (2021)

Comparison of telbivudine and entecavir on the change of off- treatment eGFR after 3 years of treatment in non-cirrhotic chronic hepatitis B patients
por: Lin, Yang-Sheng, et al.
Publicado: (2017)

Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy
por: Lin, Tien-Ching, et al.
Publicado: (2018)

Adult Living Donor Liver Transplantation Using Hepatitis B Core Antibody-Positive Grafts in Korea, a Hepatitis B-endemic Region
por: Kim, Hee Yeon, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ujlv0bss6mjrr60vlp0g6furlr